Hepa 1-6 Mouse Liver Cancer Cell Line
Introduction
The Hepa 1-6 mouse liver cancer cell line is a derivative of the BW7756 tumor originally established in C57/L mice. The cell line has been tested and confirmed to be ectromelia virus (ECTV) negative. OriCell™ Hepa 1-6 Mouse Liver Cancer Cell Line is widely used in hepatocellular carcinoma research, in vivo tumor model establishment, and pharmacological studies.
When citing our products in academic publications, please use the following format: "OriCell™ [Product Name] + [Catalog Number], from Cyagen Biosciences."
Product Information
| Product Name | OriCell™ Hepa 1-6 Mouse Liver Cancer Cell Line |
| Alternative Name | Hepa 1-6 |
| Catalog Number | M1-0201 |
| Amount of Cells | 1×106 cells/vial |
| Tissue Origin | Mouse Liver |
| Cell Characteristics | Adherent Growth; Epithelial-like |
| Culture Conditions | 95% air; 5% CO2; 37 ℃ |
| Culture Medium | DMEM + 10% FBS |
| Doubling Time | 24 ~ 48 h |
| Biosafety Level | 1 |
| Storage at | Liquid Nitrogen (-196 ℃) |
| Precautions | —— |
QC
- Pass the detection of bacteria, fungi, mycoplasma, and endotoxins.
- Verified by cell recovery viability testing.
Please refer to "COA" for details.
General Handling Principles
- Maintain strict aseptic technique. Ensure complete sterility throughout all procedures, particularly within the laminar flow hood and incubator.
- Follow standardized protocols. Adhere strictly to the product manual. Implement rigorous control over experimental variables and include appropriate parallel controls.
- Use high-quality consumables and reagents. This product requires culture vessels suitable for adherent growth, and the reuse of these vessels is not recommended. The reagents used must be validated for reliability, cell compatibility, and batch-to-batch consistency.
Warm Notice: The cryopreservation medium of this product contains DMSO, which may pose potential risks. Please handle it with care.